7 studies were found.

1.		Recruiting	Continuation Study of CpG 7909 in Patients with Stable Disease or Who Have Responded to Therapy for their Malignancies Condition: Neoplasm Metastasis
2.		Recruiting	CPG 7909 in Melanoma Condition: Melanoma
3.		Recruiting	CpG 7909 in Patients with Cutaneous T-Cell Lymphoma Condition: Lymphoma, T-Cell, Cutaneous
4.		Recruiting	CpG 7909 in Patients with Stage IV Renal Cell Cancer Conditions: Renal Cell Cancer; Post Nephrectomy
5.		No longer recruiting	CPG 7909 Injection in non-small cell lung cancer Condition: Carcinoma, Non-Small-Cell Lung
6.		No longer recruiting	A Phase I/II Open Label, Multi-Center Dose-Escalation Study of s.c. CpG 7909 plus Herceptin in Patients with Metastatic Breast Cancer Conditions: Breast Neoplasms - Phase I; Neoplasm Metastasis - Phase II
7.		Completed	Safety and efficacy study of the combination of CpG 7909 and Herceptin in patients with metastatic breast cancer Conditions: Breast Neoplasms; Neoplasm Metastasis